Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVO) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Evotec SE (EVO) over the last 9 years, with Q3 2025 value amounting to $207.7 million.

  • Evotec SE's Shares Outstanding (Weighted Average) rose 664.39% to $207.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.7 million, marking a year-over-year increase of 664.39%. This contributed to the annual value of $189.5 million for FY2024, which is 47.03% down from last year.
  • Per Evotec SE's latest filing, its Shares Outstanding (Weighted Average) stood at $207.7 million for Q3 2025, which was up 664.39% from $189.5 million recorded in Q4 2024.
  • Evotec SE's 5-year Shares Outstanding (Weighted Average) high stood at $207.7 million for Q3 2025, and its period low was $1768.9 during Q3 2021.
  • For the 5-year period, Evotec SE's Shares Outstanding (Weighted Average) averaged around $164.4 million, with its median value being $190.4 million (2023).
  • Over the last 5 years, Evotec SE's Shares Outstanding (Weighted Average) had its largest YoY gain of 1007178768.4% in 2022, and its largest YoY loss of 531.2% in 2022.
  • Evotec SE's Shares Outstanding (Weighted Average) (Quarter) stood at $190.4 million in 2021, then fell by 5.31% to $180.3 million in 2022, then increased by 5.6% to $190.4 million in 2023, then decreased by 0.47% to $189.5 million in 2024, then increased by 9.63% to $207.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $207.7 million for Q3 2025, versus $189.5 million for Q4 2024 and $194.8 million for Q3 2024.